3-氨基-4-硝基苯腈 | 99512-10-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氨基-4-硝基苯腈
• 中文别名: 3-氨基-4-硝基苯甲腈
• 英文名称: 3-amino-4-nitrobenzonitrile
• CAS: 99512-10-4
• 化学式: C₇H₅N₃O₂
• 分子量: 163.136
• InChiKey: VKQPDHKSUIHUDF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  95.6
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  6.1
• 海关编码：
  2926909090
• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P261,P280,P302+P352
• 危险品运输编号：
  3439
• 危险性描述：
  H302,H311,H317
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Amino-4-nitrobenzonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Amino-4-nitrobenzonitrile
CAS number: 99512-10-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H5N3O2
Molecular weight: 163.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氨基-4-硝基苯腈 在 盐酸 作用下， 以 水 为溶剂， 反应 48.0h， 以83%的产率得到3-氨基-4-硝基苯甲酸
  参考文献：
  名称：

  [EN] HETEROCYCLIC KINASE INHIBITORS
  [FR] INHIBITEURS DE KINASE HETEROCYCLIQUE

  摘要：

  具有公式(I)的化合物对于抑制蛋白激酶是有用的。还公开了制造这些化合物的方法、包含这些化合物的组合物以及使用这些化合物的治疗方法。

  公开号：

  WO2004076424A1
• 作为产物：
  描述：

  2-硝基-5-氯苯胺 在 四(三苯基膦)钯 zinc(II) cyanide 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 96.0h， 以23%的产率得到3-氨基-4-硝基苯腈
  参考文献：
  名称：

  [EN] HETEROCYCLIC KINASE INHIBITORS
  [FR] INHIBITEURS DE KINASE HETEROCYCLIQUE

  摘要：

  具有公式(I)的化合物对于抑制蛋白激酶是有用的。还公开了制造这些化合物的方法、包含这些化合物的组合物以及使用这些化合物的治疗方法。

  公开号：

  WO2004076424A1

文献信息

• [EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS D'HISTONE DEACETYLASE
  申请人：METHYLGENE INC

  公开号：WO2005030704A1

  公开（公告）日：2005-04-07

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  这项发明涉及抑制组蛋白去乙酰化酶。该发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。该发明还提供了治疗细胞增殖性疾病和症状的组合物和方法。
• The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB₁ Receptor Positive Allosteric Modulators
  作者：Chih-Chung Tseng、Gemma Baillie、Giulia Donvito、Mohammed A. Mustafa、Sophie E. Juola、Chiara Zanato、Chiara Massarenti、Sergio Dall’Angelo、William T. A. Harrison、Aron H. Lichtman、Ruth A. Ross、Matteo Zanda、Iain R. Greig

  DOI：10.1021/acs.jmedchem.9b00252

  日期：2019.5.23

  (e.g., ZCZ011) featured a 3-nitroalkyl-2-phenyl-indole structure. Although a small number of drugs include the nitro group, it is generally not regarded as being "drug-like", and this is particularly true for aliphatic nitro groups. There are very few case studies where an appropriate bioisostere replaced a nitro group that had a direct role in binding. This may be indicative of the difficulty of replicating

  第一代CB1阳性变构调节剂（例如ZCZ011）具有3-硝基烷基-2-苯基-吲哚结构。尽管少数药物包含硝基，但通常不认为它是“类药物”，对于脂肪族硝基尤其如此。在很少的案例研究中，适当的生物甾体替代了在结合中具有直接作用的硝基。这可能表明复制其结合相互作用的困难。在本文中，我们报道了针对CB1大麻素受体的变构结合位点的配体的设计和合成，其中CF3基团成功取代了脂肪族NO2。通常，带有 的化合物比它们的 当量更有效，并且还显示出改善的体外代谢稳定性。选择性能最佳平衡的 类似物（1）进行进一步的药理评估。体内试验研究表明（±）-1具有与（±）-ZCZ011相似的活性，两者在神经性疼痛的小鼠模型中均显示出有希望的功效。
• Sulfonamide bridging compounds that inhibit tryptase activity
  申请人：Array Biopharma Inc.

  公开号：US06221914B1

  公开（公告）日：2001-04-24

  The present invention is directed to compounds which are capable of inhibiting the activity of tryptase. Such compounds are useful in the treatment or prevention of inflammatory disease, particularly those disease states which are mediated by mast cell activation. Also encompassed by the invention are formulations comprising the noted compounds, processes for preparing such compounds and methods for treating or preventing an inflammatory disease.

  本发明涉及一种能够抑制色氨酸蛋白酶活性的化合物。这些化合物对于治疗或预防炎症性疾病是有用的，特别是那些由肥大细胞激活介导的疾病状态。该发明还包括含有上述化合物的配方、制备这种化合物的方法以及治疗或预防炎症性疾病的方法。
• FeCl₃-Catalyzed synthesis of pyrrolo[1,2-a]quinoxaline derivatives from 1-(2-aminophenyl)pyrroles through annulation and cleavage of cyclic ethers
  作者：Zhenyu An、Lianbiao Zhao、Mingzhong Wu、Jixiang Ni、Zhenjie Qi、Guiqin Yu、Rulong Yan

  DOI：10.1039/c7cc07089f

  日期：——

  1-(2-aminophenyl)pyrroles and cyclic ethers, which includes functionalization of C(sp3)-H bonds and the construction of C–C and C–N bonds, has been developed. The features of this reaction are Fe catalysis, low-cost and readily accessible starting materials. Moreover, this procedure exhibits good functional group tolerance and a series of pyrrolo[1,2-a]quinoxaline derivatives are obtained in moderate to good

  一种直接的铁催化从1-（2-氨基苯基）吡咯和环醚合成吡咯并[1,2- a ]喹喔啉的方法，包括C（sp 3）-H键的官能化和C–的构建已经开发了C和C–N键。该反应的特征是铁催化，低成本和易于获得的起始原料。此外，该方法表现出良好的官能团耐受性，并且以中等至良好的产率获得了一系列吡咯并[1,2- a ]喹喔啉衍生物。
• <i>N</i>,<i>N</i>-Dimethylformamide as Carbon Synthons for the Synthesis of <i>N</i>-Heterocycles: Pyrrolo/Indolo[1,2-<i>a</i>]quinoxalines and Quinazolin-4-ones
  作者：Shichen Li、Jianing Ren、Chengcheng Ding、Yishou Wang、Chen Ma

  DOI：10.1021/acs.joc.1c02067

  日期：2021.12.3

  N-dimethylformamide (DMF) as synthetic precursors contributing especially the methyl, acyl, and amino groups has played a significant role in heterocycle syntheses and functionalization. In this protocol, a wide range of pyrrolo/indolo[1,2-a]quinoxalines and quinazolin-4-ones were obtained in moderate to good yields by using elemental iodine without any metal or peroxides. We considered that N-methyl and

  N , N-二甲基甲酰胺 (DMF) 作为合成前体，尤其是甲基、酰基和氨基，在杂环合成和功能化中发挥了重要作用。在该协议中，通过使用不含任何金属或过氧化物的元素碘，以中等至良好的收率获得了范围广泛的 pyrrolo/indolo[1,2 - a ]quinoxalines 和 quinazolin-4-ones。我们认为DMF的N-甲基和N-酰基通过不同的机理分别参与并完成反应，这表明DMF的潜力仍有待探索。